MT | ||
---|---|---|
OUTLOOK RATING 1..100 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 49 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 59 | |
P/E GROWTH RATING 1..100 | 4 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HAP | MT | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago78% | 4 days ago76% |
Momentum ODDS (%) | 4 days ago73% | 4 days ago66% |
MACD ODDS (%) | 4 days ago72% | 4 days ago55% |
TrendWeek ODDS (%) | 4 days ago80% | 4 days ago74% |
TrendMonth ODDS (%) | 4 days ago80% | 4 days ago70% |
Advances ODDS (%) | 4 days ago81% | 4 days ago70% |
Declines ODDS (%) | 11 days ago76% | 8 days ago71% |
BollingerBands ODDS (%) | 4 days ago89% | 4 days ago73% |
Aroon ODDS (%) | 4 days ago81% | 4 days ago68% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DSCIX | 14.67 | 0.31 | +2.16% |
Dana Epiphany Small Cap Eq Instl | |||
FIJYX | 36.91 | 0.60 | +1.65% |
Fidelity Advisor Biotechnology Z | |||
MDDIX | 13.16 | 0.11 | +0.84% |
MassMutual Diversified Value I | |||
SHSAX | 72.95 | 0.30 | +0.41% |
BlackRock Health Sciences Opps Inv A | |||
HNDRX | 74.47 | 0.24 | +0.32% |
Horizon Defined Risk Investor |
A.I.dvisor indicates that over the last year, HAP has been closely correlated with SHEL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if HAP jumps, then SHEL could also see price increases.